Confirmatory Study on the Efficacy and Safety of the Fixed-dose Combination of Desloratadine/Betamethasone Versus Desloratadine

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
Phase IIIb , longitudinal, multicenter, randomized, double-blind, to evaluate efficacy and safety of the fixed-dose combination of Desloratadine 5 mg / Betamethasone 0.25 mg versus Desloratadine 5 mg monotherapy as treatment for symptoms associated with allergic rhinitis.
Epistemonikos ID: 76a0ec6b272d6b71f3291275cb105f8ed6fa8c15
First added on: Apr 09, 2025